EPO and Behcet disease: Previous data have demonstrated that some medications may provide potential benefits to cognitive impairment in euthymic BD patients (e.g., cholinesterase inhibitors [43], corticosteroid receptor antagonists [44], dopaminergic agonists [45], intranasal insulin [46], several antioxidants, and erythropoietin [47], amongst others).